Their findings attempt to establish novel cooperation and coordination between oncogenic Rho GTPase/F-actin function and the tumor-suppressive LATS1/2 (Hippo pathway) as two synergistic components of the STARD13-correlated ceRNA in modulating breast CSC characteristics. Here, LATS1 is linked to neoplasm.